MGMT and central nervous system cancer: It is reported that the main mechanism of glioma cell resistant to TMZ is linked to the expression of the O6‐methylguanine DNA methyltransferase (MGMT) gene.4 Thus, it is necessary to identify an effective antiglioblastoma drug for brain cancer patients, especially for those resistant to TMZ.